Uncovering a new vulnerability in acute myeloid leukemia
The team explored the possibility of leveraging the new vulnerability to overcome therapy resistance.
Read More
The team explored the possibility of leveraging the new vulnerability to overcome therapy resistance.
Read MoreThe findings suggest that P-bodies might be an Achilles’ heel of acute myeloid leukemia, opening new avenues for developing anticancer agents to treat this condition.
Read MoreExploiting this vulnerability resulted in rapid tumor regression in animal models of AML.
Read MoreThe findings support taking the next step toward bringing a potential new treatment to the clinic.
Read More